Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Εμφάνιση άλλων εκδόσεων (1)

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Sandham, D, Chen, W, Hardman, C, Luo, J, Xue, L, Ogg, G, Erpenbeck, V
Μορφή:	Conference item
Γλώσσα:	English
Έκδοση:	Wiley 2019

Παρόμοια τεκμήρια

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
ανά: Chen, W, κ.ά.
Έκδοση: (2018)

Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
ανά: Xue, L, κ.ά.
Έκδοση: (2018)

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
ανά: Hardman, C, κ.ά.
Έκδοση: (2019)

Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
ανά: Xue, L, κ.ά.
Έκδοση: (2019)

IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
ανά: Hardman, CS, κ.ά.
Έκδοση: (2021)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells
ανά: Xue, L, κ.ά.
Έκδοση: (2013)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.
ανά: Xue, L, κ.ά.
Έκδοση: (2014)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
ανά: Ogg, G, κ.ά.
Έκδοση: (2015)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
ανά: Salimi, M, κ.ά.
Έκδοση: (2015)

Role of Mast Cells and Type 2 Innate Lymphoid (ILC2) Cells in Lung Transplantation
ανά: Esmaeil Mortaz, κ.ά.
Έκδοση: (2018-01-01)

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells
ανά: Luo, J, κ.ά.
Έκδοση: (2019)

Group 2 Innate Lymphoid Cells (ILC2) Suppress Beneficial Type 1 Immune Responses During Pulmonary Cryptococcosis
ανά: Markus Kindermann, κ.ά.
Έκδοση: (2020-02-01)

Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules
ανά: Noha Mousaad Elemam, κ.ά.
Έκδοση: (2017-12-01)

Monitoring Cellular Movement with Photoconvertible Fluorescent Protein and Single-Cell RNA Sequencing Reveals Cutaneous Group 2 Innate Lymphoid Cell Subtypes, Circulating ILC2 and Skin-Resident ILC2
ανά: Minori Nakatani-Kusakabe, κ.ά.
Έκδοση: (2021-09-01)

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells
ανά: Hardman, C, κ.ά.
Έκδοση: (2017)

Cysteinyl leukotriene E4 activates human ILC2s and enhances the effect of prostaglandin D2 and epithelial cytokines
ανά: Salimi, M, κ.ά.
Έκδοση: (2017)

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
ανά: Veit J. Erpenbeck, κ.ά.
Έκδοση: (2016-12-01)

The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation
ανά: Christian Domingo, κ.ά.
Έκδοση: (2018-09-01)

Group 2 innate lymphoid cells and asthma
ανά: Hiroki Kabata, κ.ά.
Έκδοση: (2015-07-01)

Immunoregulatory Sensory Circuits in Group 3 Innate Lymphoid Cell (ILC3) Function and Tissue Homeostasis
ανά: Rita G. Domingues, κ.ά.
Έκδοση: (2020-02-01)

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial
ανά: Gonem, S, κ.ά.
Έκδοση: (2016)

Prostaglandin E2 Inhibits Group 2 Innate Lymphoid Cell Activation and Allergic Airway Inflammation Through E-Prostanoid 4-Cyclic Adenosine Monophosphate Signaling
ανά: Yu Zhou, κ.ά.
Έκδοση: (2018-03-01)

Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa
ανά: Andreea Petrasca, κ.ά.
Έκδοση: (2023-01-01)

Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa.
ανά: Andreea Petrasca, κ.ά.
Έκδοση: (2023-01-01)

Evaluation of Innate Lymphoid Cells (ILCs) Population in the Mouse Model of Colorectal Cancer
ανά: Seyed Mohammad Javadzadeh, κ.ά.
Έκδοση: (2022-12-01)

ILC-You in the Thymus: A Fresh Look at Innate Lymphoid Cell Development
ανά: Samuel B. Shin, κ.ά.
Έκδοση: (2021-05-01)

Testosterone Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation
ανά: Jacqueline-Yvonne Cephus, κ.ά.
Έκδοση: (2017-11-01)

Prostaglandin D2 receptor 2 downstream signaling and modulation of type 2 innate lymphoid cells from patients with asthma.
ανά: Christina Gress, κ.ά.
Έκδοση: (2024-01-01)

Group 2 Innate Lymphoid Cells in Allergic Rhinitis
ανά: Wang S, κ.ά.
Έκδοση: (2024-11-01)

Group 2 innate lymphoid cells and their surrounding environment
ανά: Maiko Naito, κ.ά.
Έκδοση: (2023-03-01)

Group 2 innate lymphoid cells in human asthma
ανά: Arifumi Iwata, κ.ά.
Έκδοση: (2023-04-01)

The Fate of Activated Group 2 Innate Lymphoid Cells
ανά: Laura Mathä, κ.ά.
Έκδοση: (2021-04-01)

Increased circulating innate lymphoid cell (ILC)1 and decreased circulating ILC3 are involved in the pathogenesis of Henoch-Schonlein purpura
ανά: Lili Zhang, κ.ά.
Έκδοση: (2022-04-01)

IL-33-induced keratoconjunctivitis is mediated by group 2 innate lymphoid cells in mice
ανά: Yuka Hosotani, κ.ά.
Έκδοση: (2023-04-01)

The Functional Role of Group 2 Innate Lymphoid Cells in Asthma
ανά: Takahiro Matsuyama, κ.ά.
Έκδοση: (2023-05-01)

Tissue Resident and Migratory Group 2 Innate Lymphoid Cells
ανά: Laura Mathä, κ.ά.
Έκδοση: (2022-04-01)

Group 2 Innate Lymphoid Cells in Respiratory Allergic Inflammation
ανά: Sofia Helfrich, κ.ά.
Έκδοση: (2019-06-01)

The Regulation of the IL-18 on Group 2 Innate Lymphoid Cells in Allergic Rhinitis
ανά: Chuling Li, κ.ά.
Έκδοση: (2021-09-01)

The role of type 2 innate lymphoid cells in the pathogenesis of atopic dermatitis
ανά: Salimi, M, κ.ά.
Έκδοση: (2014)

The roles of type 2 cytotoxic T cells in inflammation, tissue remodeling, and prostaglandin (PG) D2 production are attenuated by PGD2 receptor 2 antagonism
ανά: Chen, W, κ.ά.
Έκδοση: (2021)